Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-018724
Filing Date
2024-06-14
Accepted
2024-06-14 16:28:19
Documents
1
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 10679
  Complete submission text file 0001127602-24-018724.txt   12402
Mailing Address ANNALY CAPITAL MANAGEMENT, INC. 1211 AVE. OF THE AMERICAS NEW YORK NY 10036
Business Address
Hannan Kathy Hopinkah (Reporting) CIK: 0001767813 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40097 | Film No.: 241045259

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)